GFAP and early-onset autosomal dominant Alzheimer disease: It has previously been shown that pelargonidin could significantly attenuate MDA and catalase activity in the hippocampus, decrease glial fibrillary acidic protein (GFAP) levels, and thereby improve memory and learning functions in a rat model of Alzheimer’s disease [25].